Turning cost effectiveness analysis on its head
Rev Med Virol
.
2019 Mar;29(2):e2040.
doi: 10.1002/rmv.2040.
Epub 2019 Feb 7.
Author
Paul D Griffiths
PMID:
30734398
DOI:
10.1002/rmv.2040
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cost-Benefit Analysis
Cytomegalovirus*
Humans
Pregnancy